ArticleAsian biomedicine : research, reviews and news2026
Prevalence of economic burden of overweight and obesity and their associated factors in Saudi Arabia.
Article in Asian biomedicine : research, reviews and news, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Overweight and obesity represent significant public health challenges in Saudi Arabia with substantial economic implications. Objective: To estimate the economic burden of overweight and obesity in Saudi Arabia and identify associated factors. Methods: This cross-sectional study utilized a mixed-methods approach combining primary survey data with secondary national health data. A total of 667 participants were recruited through stratified random sampling using a validated structured questionnaire. Direct medical costs were estimated using healthcare utilization data, while indirect costs were calculated using the human capital approach. Logistic regression analysis identified factors associated with high economic burden. Statistical significance was set at Results: The total annual economic burden of overweight and obesity in Saudi Arabia was estimated at SAR 7.6 billion (US$2.0 billion), representing 1.2% of GDP. Direct medical costs accounted for SAR 5.2 billion, while indirect costs totaled SAR 2.4 billion. Among participants, 46.8% experienced a high individual economic burden. Younger age (18-30 years) was significantly associated with higher economic burden compared to older adults (adjusted odds ratio [AOR] = 2.9, 95% confidence interval [CI]: 2.2-4.0, Conclusion: The economic burden of overweight and obesity in Saudi Arabia is substantial and disproportionately affects younger adults, individuals with lower education, and those with higher BMI. These findings support targeted interventions and policy initiatives aligned with Saudi Vision 2030 healthcare transformation goals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.